141 related articles for article (PubMed ID: 29781401)
1. Screening of prognostic risk microRNAs for acute myeloid leukemia.
Gao HY; Wang W; Luo XG; Jiang YF; He X; Xu P; Chen X; Li XY
Hematology; 2018 Dec; 23(10):747-755. PubMed ID: 29781401
[TBL] [Abstract][Full Text] [Related]
2. Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
Zhang C; Bai G; Zhu W; Bai D; Bi G
Med Sci Monit; 2017 Oct; 23():4705-4714. PubMed ID: 28965123
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia.
Ye J; Luo D; Yu J; Zhu S
Hematology; 2019 Dec; 24(1):487-491. PubMed ID: 31210592
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
[TBL] [Abstract][Full Text] [Related]
5. Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family.
Chen H; Liu T; Liu J; Feng Y; Wang B; Wang J; Bai J; Zhao W; Shen Y; Wang X; Yang J; Ji Y; He A; Yang Y
Cell Physiol Biochem; 2018; 47(5):1998-2007. PubMed ID: 29969755
[TBL] [Abstract][Full Text] [Related]
6. Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.
Kotaki R; Higuchi H; Ogiya D; Katahira Y; Kurosaki N; Yukihira N; Ogata J; Yamamoto H; Mohamad Alba S; Azhim A; Kitajima T; Inoue S; Morishita K; Ono K; Koyama-Nasu R; Kotani A
Int J Hematol; 2017 Dec; 106(6):811-819. PubMed ID: 28831750
[TBL] [Abstract][Full Text] [Related]
7. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.
Zhao Y; Zhang X; Zhao Y; Kong D; Qin F; Sun J; Dong Y
Med Oncol; 2015 May; 32(5):152. PubMed ID: 25832863
[TBL] [Abstract][Full Text] [Related]
9. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y
BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251
[TBL] [Abstract][Full Text] [Related]
10. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
11. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
[TBL] [Abstract][Full Text] [Related]
12. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
13. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Shi M; Xu G
BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in acute myeloid leukemia.
Liao Q; Wang B; Li X; Jiang G
Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
[TBL] [Abstract][Full Text] [Related]
18. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR‑135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression.
Xu H; Wen Q
Mol Med Rep; 2018 Jul; 18(1):1134-1140. PubMed ID: 29845297
[TBL] [Abstract][Full Text] [Related]
20. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.
Lin XC; Xu Y; Sun GP; Wen JL; Li N; Zhang YM; Yang ZG; Zhang HT; Dai Y
Int J Oncol; 2016 Jun; 48(6):2367-80. PubMed ID: 27082628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
